Related Experiment Videos

High density lipoproteins, insulin secretion and coronary risk factors in latent coronary insufficiency

Insights

This study found no significant difference in high-density lipoprotein (HDL) cholesterol between men with and without preclinical coronary heart disease (CHD). Physical activity correlated with HDL, while inactivity linked to higher insulin secretion.

Area of Science:

  • Cardiology
  • Metabolic Syndrome
  • Preventive Medicine

Background:

  • Preclinical coronary heart disease (CHD) risk factors require further investigation in asymptomatic individuals.
  • Understanding the interplay of metabolic markers and early CHD is crucial for effective prevention strategies.

Purpose of the Study:

  • To investigate risk factors for preclinical coronary heart disease (CHD) in presumably healthy middle-aged men.
  • To examine the relationship between high-density lipoprotein (HDL) cholesterol, insulin secretion, and other metabolic parameters in relation to early CHD detection.

Main Methods:

  • Assessment of CHD risk factors in a cohort of presumably healthy men.
  • Coronary angiography performed on subjects with "latent CHD" to evaluate for angiographic changes.
  • Analysis of high-density lipoprotein (HDL) cholesterol, apoproteins, insulin secretion, glucose tolerance, serum triglycerides, and body weight.

Main Results:

  • No significant differences in HDL cholesterol or apoproteins were observed between men with and without preclinical CHD.
  • HDL cholesterol showed a positive correlation with physical activity.
  • Insulin secretion was positively associated with physical inactivity, increased body weight, and higher serum triglycerides.
  • Men with the highest insulin secretion exhibited the lowest glucose tolerance.

Conclusions:

  • The study confirms the established covariance between HDL cholesterol, insulin secretion, serum triglycerides, body weight, and physical activity.
  • The findings do not support the hypothesis that HDL cholesterol is a major negative risk factor in middle-aged men with preclinical CHD.

Related Concept Videos